Physician

Ricardo A Aviles, MD

According to 2025 Medicare claims, Ricardo Aviles, MD (NPI: 1205837010) practices ophthalmology in the Sierra Vista-Douglas, AZ market, with the plurality of this provider's patient population coming from Cochise, AZ. This provider's primary affiliated billing organization is RF EYE PC (NPI: 1396969713; TIN: 860879991) and primary practice location at 85635-2842.

Aviles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,278 traditional Medicare patients, billed 19,952 HCPCS/CPT codes, and received $1,871,175 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 4,932 prescription claims across 1,083 beneficiaries totaling $508,614 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 15 records totaling $368. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $568,989 to $1,871,175. Similarly, Part D prescription costs have moved sharply higher in recent years, from $193,091 to $508,614. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$936K$1.9M2015 Medicare payment: $568,989 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $571,870 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $821,114 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,021,081 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,142,206 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $984,085 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,120,066 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,178,075 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,481,725 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,871,175 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2896,296$568,989
20161,3066,739$571,870
20171,2777,994$821,114
20181,3558,332$1,021,081
20191,3478,000$1,142,206
20201,2296,796$984,085
20211,2906,924$1,120,066
20221,2337,851$1,178,075
20231,19015,707$1,481,725
20241,27819,952$1,871,175

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$737K$1.5M2015 Drug cost: $193,091 (USD; Tot_Drug_Cst)2016 Drug cost: $194,152 (USD; Tot_Drug_Cst)2017 Drug cost: $271,806 (USD; Tot_Drug_Cst)2018 Drug cost: $271,389 (USD; Tot_Drug_Cst)2019 Drug cost: $254,515 (USD; Tot_Drug_Cst)2020 Drug cost: $270,695 (USD; Tot_Drug_Cst)2021 Drug cost: $324,393 (USD; Tot_Drug_Cst)2022 Drug cost: $604,232 (USD; Tot_Drug_Cst)2023 Drug cost: $1,473,492 (USD; Tot_Drug_Cst)2024 Drug cost: $508,614 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156702,537$193,091
20166702,579$194,152
20177573,223$271,806
20187213,300$271,389
20196543,484$254,515
20206533,406$270,695
20217083,295$324,393
20228843,826$604,232
20239484,253$1,473,492
20241,0834,932$508,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system366369$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more409533$56
92083Exam of visual field with extended testing288307$43
92134Imaging of retina5431,269$27
92133Imaging of optic nerve380391$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium2787,440$41,456
XiidraLifitegrast301,800$38,743
Prednisolone AcetatePrednisolone Acetate78931,138$38,346
VyzultaLatanoprostene Bunod733,315$31,133
RestasisCyclosporine271,350$25,163

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$368Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ricardo A. Aviles, MD?

Tedicare shows public-source Medicare data for Ricardo A. Aviles, MD (NPI 1205837010), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ricardo A. Aviles, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ricardo A. Aviles, MD?

Ricardo A. Aviles, MD is linked to RF EYE PC (billing NPI 1396969713) in the available physician profile data.

Does Ricardo A. Aviles, MD have Open Payments data?

Ricardo A. Aviles, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.